America & Europe Eye Drops Market Forecast to 2031
预计到 2031 年,美国和欧洲眼药水市场规模将从 2023 年的 131.6 亿美元增至 198.8 亿美元。预计 2023 年至 2031 年市场复合年增长率为 5.3%。
不断增长的医疗支出、创新的眼药水配方、制药公司和研究机构之间的合作以及在线零售和电子商务平台的激增可能仍将是关键的市场趋势。
美国和欧洲眼药水市场分析
白内障、青光眼、干眼症和过敏等眼部疾病的发病率不断上升,导致眼科对眼药水的需求增加。老年人口的增长和对自我管理眼部护理产品的偏好也促进了北美和欧洲眼药水市场的增长。人们对眼部健康的认识不断提高,定期进行眼部检查,促进了眼部疾病的早期诊断和治疗,从而刺激了对眼药水的需求。先进的药物输送系统和配方技术确保了积极的市场前景。无防腐剂眼药水和创新药物输送技术的推出有望为美国和欧洲眼药水市场参与者提供机会。此外,电子商务平台通过提高眼部护理产品的可及性、方便的网上购物和送货上门使客户受益,特别是在实体零售店有限的地区。另一方面,产品召回数量的增加阻碍了美国和欧洲眼药水市场的增长。
美国和欧洲眼药水市场概况
干眼症患病率的增加、生活方式的改变、人们对眼部健康的认识的提高以及不可逆转的视力问题病例的激增是增加美国和欧洲国家疾病负担的主要因素。此外,老年人口的增长推动了美国和欧洲眼药水市场的增长。老年人更容易患上各种眼疾,眼药水对于治疗和预防目的是必不可少的。美国国家生物技术信息中心 (NCBI) 的一项研究发现,2021 年老年人口中干眼症的患病率约为 33%。随着老年人口的增长,干眼症、青光眼和白内障等眼疾的患病率也随之增加,从而推动了对治疗和预防眼药水产品的需求。此外,正在进行的研究和开发工作支持引入具有更高效力、更长作用时间和更少副作用的先进配方。
美国和欧洲眼药水市场驱动因素和机遇
旨在增强眼部护理意识以创造市场机会的举措
近年来,人们一直在努力提高人们对眼部疾病的认识和教育,促使患者获得合适的药物和治疗。 2023 年 8 月 28 日,疾病控制和预防中心 (CDC) 与其视力健康倡议 (VHI) 下致力于视力健康的其他组织合作,以创建一个更有效的多层网络,以防止视力丧失并支持眼部健康。 2023 年 12 月 27 日,美国眼部健康和安全组织 Prevent Blindness 宣布计划参加 2024 年 1 月的国家青光眼宣传月活动,为患者、护理伙伴和专业人士提供各种有用的资源,以教育他们有关青光眼的知识。 2023 年 10 月 1 日,2EyesVision 自豪地重申了其致力于通过西班牙工业、贸易和旅游部 (MINCOTUR) 在 Secpho 生态系统中的社区举措塑造眼科未来的承诺。该部已向 Secpho 集群提供了超过 317 万美元的赠款用于创新项目。2023 年 6 月 6 日,国家医疗服务体系 (NHS) 采取举措,让英格兰的患者更容易获得眼科护理。根据这项举措,采取措施减少眼科护理的等待时间,并将其列为“首要任务”。因此,越来越多的眼科护理举措可能会为美国和其他国家提供增长机会。欧洲眼药水市场。
与年龄相关的眼部疾病高发性推动市场增长
衰老是导致视力减弱的一个重要因素,尤其是对于 50 岁以上的人群。流行病学家预测,由于老龄化人口的增加和糖尿病等风险因素的流行,到 2040 年,受青光眼影响的人数将增加近一倍。根据美国疾病控制和预防中心 (CDC) 的数据,2022 年美国约有 1200 万 40 岁及以上的人患有视力障碍,其中 300 万人在视力矫正后出现视力障碍,800 万人因未矫正的折射率而患有视力障碍。世界卫生组织 (WHO) 指出,到 2030 年,60 岁及以上人口将从 2020 年的 10 亿激增至 14 亿;到 2050 年,这个数字可能还会翻一番,达到约 20 亿。80 岁以上老人的数量预计会在 2020 年至 2050 年期间增长两倍,达到 4.26 亿。年龄相关性黄斑变性 (AMD) 是一种复杂的眼部疾病,也是老年人无法治愈的失明的最常见原因之一。AMD 是 65 岁以上欧洲裔人群失明的最常见原因。根据参天制药的数据,2022 年美国超过 270 万 40 岁以上的人患有青光眼。预计到 2032 年和 2050 年,老年患者的数量将分别增加到约 430 万和约 550 万。医疗保健行业的不断发展导致预期寿命的增加。老年人群中眼部相关问题的高发性可能会鼓励制造商在市场上推出新的眼部护理产品,从而促进市场的增长。
美洲和欧洲眼药水市场报告细分分析
促成美洲和欧洲眼药水市场分析的关键细分市场是药物类别、应用和购买模式。
- 根据药物类别,美洲和欧洲眼药水市场分为抗生素、人工泪液、类固醇和其他。抗生素领域在 2023 年占据了最大的市场份额。然而,预计类固醇领域在预测期内的复合年增长率最高,为 6.4%。
- 根据应用,市场细分为眼部疾病、眼部护理和其他。眼部疾病领域在 2023 年占据了最大的市场份额。然而,预计眼部护理领域在预测期内的复合年增长率最高。
- 就购买模式而言,市场分为处方药和非处方药。处方药部分在 2023 年占据了市场份额的主导地位,预计在预测期内将实现 5.5% 的更高复合年增长率。。
美洲和欧洲眼药水 按地区划分的市场份额分析
美洲和欧洲眼药水市场报告的地理范围主要分为美洲和欧洲。
美国主导着美洲和欧洲眼药水市场。近 120 万美国人口患有帕金森病;它是继阿尔茨海默氏症之后第二常见的神经退行性疾病。美国在 2023 年在市场上的主导地位可以归因于该地区神经退行性疾病发病率的上升。预计欧洲在美洲和欧洲的复合年增长率将达到 4.9%。预测期内欧洲眼药水市场。
美国和欧洲眼药水市场新闻和最新发展
美国和欧洲眼药水市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是市场发展列表:
- 2023 年 7 月,博士伦公司从强生视力公司收购了 Blink 眼药水和隐形眼镜滴剂产品线。此次战略收购是该公司致力于通过推广非处方 (OTC) 解决方案来提高消费者眼部护理便利性的最新例证。 (来源:博士伦公司,新闻稿,2023 年)
- 2023 年 6 月,博士伦公司在美国推出了 Biotrue Hydration Boost 隐形眼镜补水滴眼液,这是第一款也是唯一一款不含防腐剂的补水滴眼液,可用于润滑和重新润湿软性隐形眼镜。这些产品采用多剂量瓶装,可用于日抛型和硬性透气型镜片。(来源:博士伦公司,新闻稿,2023 年)
- 2022 年 12 月,爱尔康欧洲公司推出了其创新干眼产品组合的最新成员——Systane Complete 无防腐剂润滑眼药水。这些产品现在采用易于使用的多剂量瓶装。 (来源:Alcon AG,新闻稿,2022 年)
美洲和欧洲眼药水市场报告覆盖范围和交付成果
“美洲和欧洲眼药水市场规模和预测(2021 年和 2031 年)”报告提供了涵盖以下领域的市场详细分析:
- 范围内涵盖的所有关键市场细分的区域和国家级市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 主要未来趋势
- 详细的 PEST/波特五力和 SWOT 分析
- 基于区域和国家的市场分析,涵盖关键市场趋势、主要参与者、法规和近期市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和近期发展
- 详细的公司简介
America & Europe Eye Drops Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 13.16 Billion |
Market Size by | US$ 19.88 Billion |
Global CAGR | 5.3% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By 药物类别(抗生素、人工泪液、类固醇、其他) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors that are driving the America & Europe eye drops market are the rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases.
The CAGR value of the America & Europe eye drops market during the forecasted period of 2023-2031 is 5.3%.
Answer: - The antibiotics segment held the largest share of the market in the America & Europe eye drops market and held the largest market share of 37.64% in 2023.
The eye diseases segment dominated the America & Europe eye drops market and held the largest market share of 64.85% in 2023.
The America & Europe eye drops market majorly consists of the players such Alcon AG; AbbVie Inc; Bausch & Lomb Inc; Pfizer Inc; Prestige Consumer Healthcare Inc.; Similasan Corp; Rohto Pharmaceutical Co Ltd; Sager Pharma Kft; Akorn Operating Company LLC; Santen Pharmaceutical Co., Ltd.; SERVImed Industrial S.p.A.; and I-MED Pharma Inc.
Eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection.
Alcon AG and Bausch & Lomb Inc are the top two companies that hold huge market shares in the America & Europe eye drops market.
The List of Companies - America & Europe Eye Drops Market
- Alcon AG
- AbbVie Inc
- Bausch & Lomb Inc
- Pfizer Inc
- Prestige Consumer Healthcare Inc.
- Similasan Corp
- Rohto Pharmaceutical Co Ltd
- Sager Pharma Kft
- Akorn Operating Company LLC
- Santen Pharmaceutical Co., Ltd.
- SERVImed Industrial S.p.A.
- I-MED Pharma Inc.
urope Eye Drops Market
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.